568 related articles for article (PubMed ID: 11299306)
1. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus.
Li AH; Wang HL
J Neurochem; 2001 Apr; 77(2):435-44. PubMed ID: 11299306
[TBL] [Abstract][Full Text] [Related]
2. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
Kovoor A; Celver JP; Wu A; Chavkin C
Mol Pharmacol; 1998 Oct; 54(4):704-11. PubMed ID: 9765514
[TBL] [Abstract][Full Text] [Related]
3. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
Hull LC; Llorente J; Gabra BH; Smith FL; Kelly E; Bailey C; Henderson G; Dewey WL
J Pharmacol Exp Ther; 2010 Mar; 332(3):1127-35. PubMed ID: 20008489
[TBL] [Abstract][Full Text] [Related]
4. A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.
Wang HL
Neuropharmacology; 2000 Jan; 39(3):353-63. PubMed ID: 10698001
[TBL] [Abstract][Full Text] [Related]
5. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
[TBL] [Abstract][Full Text] [Related]
6. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
[TBL] [Abstract][Full Text] [Related]
7. Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition.
Pan YZ; Li DP; Chen SR; Pan HL
Brain Res; 2004 Jan; 997(1):67-78. PubMed ID: 14715151
[TBL] [Abstract][Full Text] [Related]
8. Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide mu-opioid receptor agonists.
Blanchet C; Sollini M; Lüscher C
Mol Cell Neurosci; 2003 Oct; 24(2):517-23. PubMed ID: 14572471
[TBL] [Abstract][Full Text] [Related]
9. Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo.
Patel MB; Patel CN; Rajashekara V; Yoburn BC
Mol Pharmacol; 2002 Dec; 62(6):1464-70. PubMed ID: 12435815
[TBL] [Abstract][Full Text] [Related]
10. Functional compartmentalization of opioid desensitization in primary sensory neurons.
Samoriski GM; Gross RA
J Pharmacol Exp Ther; 2000 Aug; 294(2):500-9. PubMed ID: 10900225
[TBL] [Abstract][Full Text] [Related]
11. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
[TBL] [Abstract][Full Text] [Related]
12. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
13. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
14. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels.
Finnegan TF; Chen SR; Pan HL
J Neurophysiol; 2006 Apr; 95(4):2032-41. PubMed ID: 16306173
[TBL] [Abstract][Full Text] [Related]
15. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
16. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats.
Bie B; Pan ZZ
Mol Pain; 2005 Feb; 1():7. PubMed ID: 15813995
[TBL] [Abstract][Full Text] [Related]
17. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
18. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
Hurlé MA
J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
[TBL] [Abstract][Full Text] [Related]
19. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
[TBL] [Abstract][Full Text] [Related]
20. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
Marker CL; Luján R; Loh HH; Wickman K
J Neurosci; 2005 Apr; 25(14):3551-9. PubMed ID: 15814785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
